Internal Medicine, Endocrinology, Diabetes, & Metabolism · Tallahassee, FL
NPI
1205097565
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2633 Centennial Blvd Ste 100
Tallahassee, FL, 32308
Phone (850) 431-5404
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
1,385 services
Medicare patients, 2024
180
Average age 75
Drug cost, 2024
$1.2M
3,582 prescriptions
Company payments, 2025
$1,009
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lance M Freeman was code 99214 (office e&m - established), 172 times for 116 patients. In total Lance M Freeman billed 1,385 services in 16 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 172 | 116 | $96.81 | $17K |
| 99215 Office E&M - Established | Office | 125 | 81 | $140.98 | $18K |
| 95251 Test - Miscellaneous | Office | 41 | 25 | $27.13 | $1,112 |
| 99213 Office E&M - Established | Office | 27 | 24 | $54.89 | $1,482 |
By year: 2022 $40K for 473 services; 2023 $59K for 1,414 services; 2024 $60K for 1,385 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lance M Freeman prescribed most often to Medicare patients was Levothyroxine Sodium, with 537 prescriptions and refills. In total Lance M Freeman wrote 3,582 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 537 | 1,527 | 151 | $7,308 |
| Atorvastatin Calcium Generic | 204 | 542 | 56 | $2,238 |
| Ozempic Semaglutide | 158 | 262 | 34 | $243K |
| Synthroid Levothyroxine Sodium | 134 | 327 | 30 | $15K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 116 | 287 | 39 | $20K |
| Metformin Hcl Er Metformin Hcl | 115 | 344 | 44 | $1,831 |
| Rosuvastatin Calcium Generic | 109 | 281 | 37 | $1,033 |
| Ezetimibe Generic | 103 | 282 | 33 | $1,801 |
| Alendronate Sodium Generic | 97 | 270 | 31 | $1,230 |
| Humalog Kwikpen U-100 Insulin Lispro | 94 | 228 | 32 | $35K |
| Jardiance Empagliflozin | 86 | 189 | 20 | $104K |
| Amlodipine Besylate Generic | 82 | 222 | 25 | $886 |
| Januvia Sitagliptin Phosphate | 79 | 145 | 16 | $77K |
| Metformin Hcl Generic | 77 | 207 | 22 | $680 |
| Glimepiride Generic | 74 | 220 | 22 | $944 |
Brand drugs: 1,746 claims; generic drugs: 1,717 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lance M Freeman $1,009 ($1,009 in general payments such as food, travel and fees) from 15 companies. The largest payer was Beta Bionics, Inc. with $246.
| Company | Payments | Amount |
|---|---|---|
| Beta Bionics, Inc. BBNX | 2 | $246 |
| Dexcom, Inc. DXCM | 3 | $184 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $144 |
| Novo Nordisk Inc NVO | 4 | $87.04 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $49.92 |
| Amgen Inc. AMGN | 3 | $49.59 |
| Abbott Laboratories ABT | 2 | $48.59 |
| Eton Pharmaceuticals, Inc. ETON | 1 | $39.44 |
| Medtronic, Inc. MDT | 2 | $33.21 |
| Abbvie Inc. ABBV | 2 | $31.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.